Horizon Pharma PLC (NASDAQ:HZNP)

12.24
Data as of Oct 21
 +0.35 / +2.94%
Today’s Change
3.70
Today|||52-Week Range
18.30
+60.63%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$1.3B

Company Description

Horizon Pharma Plc is a specialty biopharmaceutical company, which engages in the business of identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. It markets a portfolio of products in arthritis, pain, inflammation and orphan diseases. The company was founded on December 20, 2011 and is headquartered in Dublin, Ireland.

Contact Information

Horizon Pharma Plc
Adelaide Chambers
Dublin Dublin 8
P:(531) 649-8521
Investor Relations:
(224) 383-3000

Employees

Shareholders

Other institutional33.65%
Mutual fund holders20.94%
Individual stakeholders0.15%

Top Executives

Timothy P. WalbertChairman, President & Chief Executive Officer
Robert W. MetzSVP-Business Operations & Government Affairs
Paul W. HoelscherChief Financial Officer & Executive Vice President
Jeffrey W. ShermanChief Medical Officer & EVP-Research & Development
John DevaneChief Scientific Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.